HPS Pharmacies wish to give notice that Pfizer Australia has discontinued DBL™ Irinotecan vials as follows:
Irinotecan hydrochloride trihydrate 40mg/2mL
Irinotecan hydrochloride trihydrate 100mg/5mL
Irinotecan hydrochloride trihydrate 500mg/25mL
HPS Pharmacies can currently access a constrained supply of Irinotecan Accord 100mg/5mL.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer Australia on 1800 675 229 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates